BPC 157: Prohibited peptide and unapproved drug in supplements The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. The peptide problem: Hype is outrunning the evidence Peptides, Drugs And Supplements: Science, Risks, And Alternatives Los Angeles Times